(-)-Trans-ε-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity

European Journal of Pharmacology

Volumn 542, Issue 1-3, 2006, Pages 54-60

  Yáñez, Matilde ^a   Fraiz, Nuria ^a   Cano, Ernesto ^a   Orallo, Francisco ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

( ) Trans viniferin; Human platelet; Human recombinant MAO isoform; Noradrenaline and 5 hydroxytryptamine uptake; Rat brain synaptosome

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CITALOPRAM; CLORGYLINE; IMIPRAMINE; IPRONIAZID; MONOAMINE OXIDASE INHIBITOR; NISOXETINE; NORADRENALIN; POLYPHENOL; RECOMBINANT ENZYME; RESORUFIN; RESVERATROL; SELEGILINE; SEROTONIN; TRITIUM; UNCLASSIFIED DRUG; VINIFERIN; BENZOFURAN DERIVATIVE; DRUG DERIVATIVE; EPSILON-VINIFERIN; FLUOXETINE; ISOENZYME; RECOMBINANT PROTEIN; STILBENE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; DEPRESSION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SYNAPTOSOME; THROMBOCYTE; WINE; ANIMAL; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOFURANS; BLOOD PLATELETS; BRAIN; CELL LINE; CITALOPRAM; CLORGYLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HUMANS; IMIPRAMINE; IPRONIAZID; ISOENZYMES; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SELEGILINE; SEROTONIN; STILBENES; SYNAPTOSOMES; TRITIUM; WINE;

EID: 33746118723     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.005     Document Type: Article

References (28)

1. Abell C.W., and Kwan S.W. Molecular characterization of monoamine oxidases A and B. Prog. Nucleic Acid Res. Mol. Biol. 65 (2001) 129-156
2. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840
3. Alarcón de la Lastra C., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49 (2005) 405-430
4. Billard C., Izard J.C., Roman V., Kern C., Mathiot C., Mentz F., and Kolb J.P. Comparative antiproliferative and apoptotic effects of resveratrol, ε-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk. Lymphoma 43 (2002) 1991-2002
5. Billingsley A.J., Brammer N.T., Wood M.D., and Minchin M.C. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat. Neuropharmacology 28 (1989) 33-36
6. Bolden-Watson C., and Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52 (1993) 1023-1029
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Delmas D., Jannin B., and Latruffe N. Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 49 (2005) 377-395
9. Edmondson D.E., Mattevi A., Binda C., Li M., and Hubalek F. Structure and mechanism of monoamine oxidase. Curr. Med. Chem. 11 (2004) 1983-1993
10. Gareri P., Falconi U., De Fazio P., and De Sarro G. Conventional and new antidepressant drugs in the elderly. Prog. Neurobiol. 61 (2000) 353-396
11. Hajos F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Res. 93 (1975) 485-489
12. 3H]5-hydroxytryptamine uptake in rat synaptosomes. Biochem. Pharmacol. 57 (1999) 111-120
13. Martin D.C., Adams R.J., and Introna R.P. Halothane inhibits 5-hydroxytryptamine uptake by synaptosomes from rat brain. Neuropharmacology 29 (1990) 9-16
14. Olas B., and Wachowicz B. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 16 (2005) 251-260
15. Orallo F. Biological effects of cis- versus trans-resveratrol. In: Aggarwal B.B., and Shishodia S. (Eds). Resveratrol in Health and Disease (2005), CRC Press, Boca Raton, USA 577-600
16. Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem. 13 (2006) 87-98
17. Orallo F., Álvarez E., Camiña M., Leiro J.M., Gómez E., and Fernández P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 61 (2002) 294-302
18. Oshima Y., Namao K., Kamijou A., Matsuoka S., Nakano M., Terao K., and Ohizumi Y. Powerful hepatoprotective and hepatotoxic plant oligostilbenes, isolated from the Oriental medicinal plant Vitis coignetiae (Vitaceae). Experientia 51 (1995) 63-66
19. Piver B., Berthou F., Dreano Y., and Lucas D. Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. Life Sci. 73 (2003) 1199-1213
20. Privat C., Telo J.P., Bernardes-Genisson V., Vieira A., Souchard J.P., and Nepveu F. Antioxidant properties of trans-ε-viniferin as compared to stilbene derivatives in aqueous and nonaqueous media. J. Agric. Food Chem. 50 (2002) 1213-1217
21. Quiney C., Dauzonne D., Kern C., Fourneron J.D., Izard J.C., Mohammad R.M., Kolb J.P., and Billard C. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Leuk. Res. 28 (2004) 851-861
22. Rausch J.L., Johnson M.E., Li J., Hutcheson J., Carr B.M., Corley K.M., Gowans A.B., and Smith J. Serotonin transport kinetics correlated between human platelets and brain synaptosomes. Psychopharmacology 180 (2005) 391-398
23. To S.E., Zepf R.A., and Woods A.G. The symptoms, neurobiology, and current pharmacological treatment of depression. J. Neurosci. Nurs. 37 (2005) 102-107
24. Ulrich S., Wolter F., and Stein J.M. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol. Nutr. Food Res. 49 (2005) 452-461
25. Vilar S., Quezada E., Santana L., Uriarte E., Yáñez M., Fraiz N., Alcaide C., Cano E., and Orallo F. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg. Med. Chem. Lett. 16 (2006) 257-261
26. Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr. Med. Chem. 5 (1998) 137-162
27. Zhou C.X., Kong L.D., Ye W.C., Cheng C.H., and Tan R.X. Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense. Planta Med. 67 (2001) 158-161
28. Zhou M., and Panchuk-Voloshina N. A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal. Biochem. 253 (1997) 169-174